166 related articles for article (PubMed ID: 26676859)
41. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
[TBL] [Abstract][Full Text] [Related]
42. Effect of Transcatheter Intra-Arterial Therapies on Tumor Interstitial Fluid Pressure and Its Relation to Drug Penetration in a Rabbit Liver Tumor Model.
Liang B; Chen S; Li L; Liu Y; Xiong F; Dong X; Feng G; Gupta S; Zheng C
J Vasc Interv Radiol; 2015 Dec; 26(12):1879-86. PubMed ID: 26254117
[TBL] [Abstract][Full Text] [Related]
43. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.
Hong K; Khwaja A; Liapi E; Torbenson MS; Georgiades CS; Geschwind JF
Clin Cancer Res; 2006 Apr; 12(8):2563-7. PubMed ID: 16638866
[TBL] [Abstract][Full Text] [Related]
44. An In Vitro Evaluation of Four Types of Drug-Eluting Embolics Loaded with Idarubicin.
Guiu B; Hincapie G; Thompson L; Wu Y; Boulin M; Cassinotto C; Cruise GM
J Vasc Interv Radiol; 2019 Aug; 30(8):1303-1309. PubMed ID: 31155500
[TBL] [Abstract][Full Text] [Related]
45. Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.
Aliberti C; Carandina R; Sarti D; Mulazzani L; Catalano V; Felicioli A; Coschiera P; Fiorentini G
Anticancer Res; 2016 Jul; 36(7):3515-21. PubMed ID: 27354617
[TBL] [Abstract][Full Text] [Related]
46. In vivo evaluation of irinotecan-loaded QuadraSphere microspheres for use in chemoembolization of VX2 liver tumors.
Tanaka K; Maeda N; Osuga K; Higashi Y; Hayashi A; Hori Y; Kishimoto K; Morii E; Ohashi F; Tomiyama N
J Vasc Interv Radiol; 2014 Nov; 25(11):1727-35.e1. PubMed ID: 25239839
[TBL] [Abstract][Full Text] [Related]
47. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
Song MJ; Chun HJ; Song DS; Kim HY; Yoo SH; Park CH; Bae SH; Choi JY; Chang UI; Yang JM; Lee HG; Yoon SK
J Hepatol; 2012 Dec; 57(6):1244-50. PubMed ID: 22824821
[TBL] [Abstract][Full Text] [Related]
48. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor.
Choi JW; Park JH; Baek SY; Kim DD; Kim HC; Cho HJ
Colloids Surf B Biointerfaces; 2015 Aug; 132():305-12. PubMed ID: 26057730
[TBL] [Abstract][Full Text] [Related]
49. A calorimetric investigation of doxorubicin-polymer bead interactions.
Waters LJ; Swaine TS; Lewis AL
Int J Pharm; 2015 Sep; 493(1-2):129-33. PubMed ID: 26209073
[TBL] [Abstract][Full Text] [Related]
50. Preservation of the active lactone form of irinotecan using drug eluting beads for the treatment of colorectal cancer metastases.
Tang Y; Czuczman PR; Chung ST; Lewis AL
J Control Release; 2008 Apr; 127(1):70-8. PubMed ID: 18237814
[TBL] [Abstract][Full Text] [Related]
51. Spatiotemporal dynamics of doxorubicin elution from embolic beads within a microfluidic network.
Carugo D; Capretto L; Roy B; Carboni M; Caine M; Lewis AL; Hill M; Chakraborty S; Zhang X
J Control Release; 2015 Sep; 214():62-75. PubMed ID: 26160306
[TBL] [Abstract][Full Text] [Related]
52. Delivery of encapsulated Doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer contrast agents.
Eisenbrey JR; Soulen MC; Wheatley MA
IEEE Trans Biomed Eng; 2010 Jan; 57(1):24-8. PubMed ID: 19709952
[TBL] [Abstract][Full Text] [Related]
53. New insights into the mechanisms of the interactions between doxorubicin and the ion-exchange hydrogel DC Bead™ for use in transarterial chemoembolization (TACE).
Biondi M; Fusco S; Lewis AL; Netti PA
J Biomater Sci Polym Ed; 2012; 23(1-4):333-54. PubMed ID: 21255482
[TBL] [Abstract][Full Text] [Related]
54. Drug-eluting beads loaded with antiangiogenic agents for chemoembolization: in vitro sunitinib loading and release and in vivo pharmacokinetics in an animal model.
Fuchs K; Bize PE; Dormond O; Denys A; Doelker E; Borchard G; Jordan O
J Vasc Interv Radiol; 2014 Mar; 25(3):379-87, 387.e1-2. PubMed ID: 24468044
[TBL] [Abstract][Full Text] [Related]
55. Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
Akinwande O; Scoggins C; Martin RC
Anticancer Res; 2016 Jul; 36(7):3413-8. PubMed ID: 27354601
[TBL] [Abstract][Full Text] [Related]
56. The novel highly lipophilic topoisomerase I inhibitor DB67 is effective in the treatment of liver metastases of murine CT-26 colon carcinoma.
Lopez-Barcons LA; Zhang J; Siriwitayawan G; Burke TG; Perez-Soler R
Neoplasia; 2004; 6(5):457-67. PubMed ID: 15548354
[TBL] [Abstract][Full Text] [Related]
57. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
[TBL] [Abstract][Full Text] [Related]
58. Drug-eluting particles for interventional pharmacology.
Liapi E; Lee KH; Georgiades CC; Hong K; Geschwind JF
Tech Vasc Interv Radiol; 2007 Dec; 10(4):261-9. PubMed ID: 18572139
[TBL] [Abstract][Full Text] [Related]
59. Loading profile of topotecan into polyvinyl alcohol microspheres (DC Bead™) over a 7-day period.
Kaiser J; Krämer I
J Oncol Pharm Pract; 2012 Jun; 18(2):222-8. PubMed ID: 22075006
[TBL] [Abstract][Full Text] [Related]
60. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.
Malagari K; Chatzimichael K; Alexopoulou E; Kelekis A; Hall B; Dourakis S; Delis S; Gouliamos A; Kelekis D
Cardiovasc Intervent Radiol; 2008; 31(2):269-80. PubMed ID: 17999110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
